摘要
Cinnamomum verum用来做香料肉桂并且已经用医学两个最古老的形式——印度草医学和中草药——在各种应用,如腺病、风湿病、皮肤病、消化不良、中风、肿瘤、象皮肿、滴虫、酵母菌和病毒感染中使用超过5000年。我们评估了枯茗醛(CUA)的抗癌作用(枯茗醛是植物的树皮中一个成分)和其在人肺腺癌A549细胞中癌变相关的潜在的分子生物标志物。结果表明,枯茗醛抑制增殖并且线粒体膜电位的损失表明它诱导细胞凋亡,caspase 3和9的激活,Annexin V+PI阳性细胞增加,与细胞凋亡的形态学特征,包括起泡膜,核固缩、碎裂、凋亡小体形成,与高强度和彗星尾矩。此外,枯茗醛也诱导有VAC的溶酶体空泡,抑制拓扑异构酶I和II以及端粒酶活性在剂量依赖性中的表达。进一步的研究揭示了在裸鼠模型中枯茗醛的生长抑制作用也很明显。总之,这些数据表明枯茗醛对A549细胞生长的抑制作用是伴随着涉及凋亡的增生控制,拓扑异构酶I和II以及端粒酶活性的下调,和溶酶体空泡和VAC的上调。在其他细胞系中发现了类似的效果(包括上述所有的影响),这些细胞系包括人肺鳞癌NCI-H520、结直肠腺癌COLO 205(结果未显示)。我们的数据表明,枯茗醛可能是抗癌治疗的一个潜在的制剂。
关键词: A549细胞,抗癌,枯茗醛,溶酶体空泡化,端粒酶,拓扑异构酶I,拓扑异构酶II,异种移植
图形摘要
Current Cancer Drug Targets
Title:Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as Well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde
Volume: 16 Issue: 9
Author(s): Ta-Wei Chen, Kuen-daw Tsai, Shu-mei Yang, Ho-Yiu Wong, Yi-Heng Liu, Jonathan Cherng, Kuo-Shen Chou, Yang-Tz Wang and Janise Cuizon, Jaw-Ming Cherng
Affiliation:
关键词: A549细胞,抗癌,枯茗醛,溶酶体空泡化,端粒酶,拓扑异构酶I,拓扑异构酶II,异种移植
摘要: Cinnamomum verum is used to make the spice cinnamon and has been used for more than 5000 years by both of the two most ancient forms of medicine in the words: Ayurveda and traditional Chinese herbal medicines for various applications such as adenopathy, rheumatism, dermatosis, dyspepsia, stroke, tumors, elephantiasis, trichomonas, yeast, and virus infections. We evaluated the anticancer effect of cuminaldehyde (CuA), a constituent of the bark of the plant, and its underlying molecular biomarkers associated with carcinogenesis in human lung adenocarcinoma A549 cells. The results show that cuminaldehyde suppressed proliferation and induced apoptosis as indicated by mitochondrial membrane potential loss, activation of caspase 3 and 9, increase in annexin V+PI+ cells, and morphological characteristics of apoptosis, including blebbing of plasma membrane, nuclear condensation, fragmentation, apoptotic body formation, and comet with elevated tail intensity and moment. In addition, cuminaldehyde also induced lysosomal vacuolation with increased volume of acidic compartments (VAC), suppressions of both topoisomerase I & II as well as telomerase activities in a dose-dependent manner. Further study reveals the growth-inhibitory effect of cuminaldehyde was also evident in a nude mice model. Taken together, the data suggest that the growth-inhibitory effect of cuminaldehyde against A549 cells is accompanied by downregulations of proliferative control involving apoptosis, both topoisomerase I & II as well as telomerase activities, together with an upregulation of lysosomal vacuolation and VAC. Similar effects (including all of the above-mentioned effects) were found in other cell lines, including human lung squamous cell carcinoma NCI-H520 and colorectal adenocarcinoma COLO 205 (results not shown). Our data suggest that cuminaldehyde could be a potential agent for anticancer therapy.
Export Options
About this article
Cite this article as:
Ta-Wei Chen, Kuen-daw Tsai, Shu-mei Yang, Ho-Yiu Wong, Yi-Heng Liu, Jonathan Cherng, Kuo-Shen Chou, Yang-Tz Wang and Janise Cuizon, Jaw-Ming Cherng , Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as Well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde, Current Cancer Drug Targets 2016; 16 (9) . https://dx.doi.org/10.2174/1568009616666160426125526
DOI https://dx.doi.org/10.2174/1568009616666160426125526 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brachial-Ankle Pulse Wave Velocity as a Novel Measure of Arterial Stiffness: Present Evidences and Perspectives
Current Hypertension Reviews Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications
Current Medicinal Chemistry Macrophage Differentiation to Foam Cells
Current Pharmaceutical Design HPLC as a Tool in Medicinal Chemistry for the Monitoring of Tricyclic Antidepressants in Biofluids
Mini-Reviews in Medicinal Chemistry Rosuvastatin Ameliorates Obesity and Proteinuria in Zucker Diabetic Fatty Rats
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Inflammatory Biomarkers in Peripheral Artery Disease: Diagnosis, Prognosis, and Therapeutic Challenges
Current Medicinal Chemistry Assessment of Endothelial Function by Positron Emission Tomography
Current Cardiology Reviews Editorial [Hot topic: Crucial Role of Redox Signaling in the Regulation of Heart Health (Guest Editor: Dipak K. Das)]
Current Cardiology Reviews Natural Compounds and Drug Discovery: Can Cnidarian Venom Play a Role?
Central Nervous System Agents in Medicinal Chemistry High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?
Current Pharmaceutical Design Obesity-Associated Hypertension in Childhood: A New Epidemic Problem
Current Hypertension Reviews From the Deepest Sea Shelf to the Uppermost Kitchen Cabinet Shelf: The Quest for Novel TNF-α Inhibitors
Current Topics in Medicinal Chemistry Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide
Current Medicinal Chemistry Context-Dependency of Relations Between Cardiovascular Phenotypes and Genes Involved in Sodium Homeostasis: Findings from the European Project on Genes in Hypertension
Current Hypertension Reviews Nattokinase: An Updated Critical Review on Challenges and Perspectives
Cardiovascular & Hematological Agents in Medicinal Chemistry Prebiotic Carbohydrates for Therapeutics
Endocrine, Metabolic & Immune Disorders - Drug Targets ACE2 and Diabetic Complications
Current Pharmaceutical Design Progress in Therapies for Myocardial Ischemia Reperfusion Injury
Current Drug Targets Chronic Heart Failure- Potential for Pharmacological Intervention
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Clinical Applications for Cardiovascular Magnetic Resonance Imaging at 3 Tesla
Current Cardiology Reviews